Eating disorders: identification, treatment and support

Pharmacists are well positioned to identify the signs and symptoms of an eating disorder and can provide access to sources of help and support.
Photo of two women talking, one taking notes, in a safe, warmly lit environment.
CPD module
After reading this article, test your knowledge by completing the CPD questions and receive a certificate as a record of your learning.

After reading this article you should be able to:

  • Understand what defines an eating disorder;
  • Consider the various elements of risk in relation to an eating disorder;
  • Have an awareness of guidance, treatment and management of eating disorders and associated difficulties;
  • Understand the role of medicines in the care of someone with an eating disorder.

For many patients, eating disorders manifest as severe and chronic mental health conditions. They are considered to have the highest mortality rate among all psychiatric disorders, with a standardised mortality rate of 5.9 for anorexia nervosa in comparison to 2.2 for other mental disorders​[1,2]​.

Eating disorders are characterised by disturbed food intake or eating behaviour that significantly affects physical health or psychosocial functioning and those who suffer from them display prominent body weight and shape concerns​[3,4]​. This combination of significant dissatisfaction with body shape and overvalued ideas about shape and weight is known as the core psychopathology of an eating disorder​[5]​. Perhaps more importantly, however, those with an eating disorder often find that it becomes their primary method for coping with past traumas, difficult situations or painful feelings that occur on a day-to-day basis. It is likely that a complex interaction between psychology, biology, societal pressures and values leads to the development of an eating disorder, making recovery difficult​[6,7]​.

There is uncertainty around how many people in the UK have a diagnosable eating disorder but the number has been estimated at between 1.25 and 1.37 million, with around 25% of those identifying as male​[8]​. Annual incidence rates are estimated to be 63 per 100,000 females of all ages and 7.1 per 100,000 in males. The highest incidence rates are thought to be in female adolescents aged 15–19 years​[9]​.

Some evidence suggests that the incidence of eating disorders is increasing overall​[9]​. Hospital admissions for eating disorders in the UK increased by 84% between 2015/2016 and 2020/2021, suggestive of a growing problem in the UK​[10]​. The reasons for this rise are not well understood; it has been suggested that it could be a result of increased awareness and better detection, or a consequence of increasing levels of psychological distress across society more widely​[9,11]​.

Currently eating disorders are categorised into the following types: 

  • Anorexia nervosa; 
  • Bulimia nervosa; 
  • Binge eating disorder; 
  • Avoidant-restrictive food intake disorder (ARFID);
  • Pica (where a person compulsively swallows non-food items);
  • Rumination regurgitation disorder; 
  • Other specified feeding or eating disorders (OSFED)​[4]​.

While ARFID, pica and rumination regurgitation disorder are recognised as distinct eating disorders, they do not share the same core psychopathology as the other categories of eating disorders, require significantly different treatment interventions and are not consistently seen in specialist eating disorder services, placing them outside the scope of this article. In the case of OSFED, current guidance suggests care and treatment in line with the diagnosis it most closely resembles​[12]​.  

Causes and risk factors

There are many theories about the causes of eating disorders​[13]​. For example, the reduction of calorific intake and semi-starvation mirrors eating disorder symptomology and it has been argued that the neuroendocrine changes in starvation results in the brain mechanisms of reward being activated when food intake is reduced​[14,15]​. What is not clear from theories such as this is what drives a person to engage in the process initially and how, in the case of anorexia nervosa, the person seemingly overrides the body’s weight control system​[16]​.

Twin studies give rise to evidence for a genetic component to the development of eating disorders; however, precisely how genes affect development is less clear and the field of epigenetics in eating disorders, in the same way as many other areas, is in its infancy​[17–19]​. Nonetheless, while genes may give rise to an underlying vulnerability to the development of an eating disorder, it is likely that the process of developing and maintaining an eating disorder is multifaceted and complex​[20]​. It is generally agreed that there are multiple biopsychosocial factors leading to the development of an eating disorders in individuals​[21]​.

Some of these factors are likely to be intrapersonal: there is evidence to suggest that people who display obsessive-compulsive traits in childhood, anxiety or borderline traits (e.g. emotional instability, dichotomous thinking) are more likely to develop an eating disorder in later life​[18,22,23]​. Perfectionism and low self-esteem also strongly relate to the development of eating disorder symptomology​[24,25]​. Many of these factors may also be associated to early attachment styles, suggesting that early experiences — and specifically the development of an insecure attachment style — may be a risk factor for the development of an eating disorder​[26,27]​.

While intrapersonal factors, attachment and genetics appear to be factors influencing a person’s vulnerability to developing an eating disorder, there is often a specific trigger or triggers that precipitate the development of difficulties with food and eating. These could be a traumatic or stressful event, such as bullying or sexual abuse, the development of an avoidant coping style, low confidence or low self-efficacy​[28,29]​. These factors have been shown to be related to a significant focus on shape and weight​[30–32]​.

The reason for the focus on shape and weight may result from societal and cultural influences. It is well documented that many cultures place high value on certain body types, often celebrating low weight or overly thin figures as being ideal, and these cultures tend to have high rates of eating disorders​[33]​. As Western norms in relation to weight and shape have been accepted and have become the norm in other cultures, so has an increase in weight consciousness and the prevalence of eating disorders globally​[34]​.

With the advent of social media, there has been increasing concern as to the effect of this on consumers’ mental health, with regular articles in various newspapers suggesting execrable harm to users​[35,36]​. While the evidence appears somewhat more nuanced in relation to mental health generally, there is some suggestion that social media can and does have a negative effect on body image, increasing the likelihood of engaging in dieting and weight loss — behaviours that are known risk factors for the development of an eating disorder​[37–40]​.

More recently, there has been a consensus for the need for early intervention in eating disorders, with the suggestion that the earlier a person engages in treatment, the more successful intervention is likely to be​[41]​. Rates of recovery can be as high as 84%, although remission rates vary across presentations and the longer the illness duration, the less the likelihood of recovery​[20,42]​.

While people with an eating disorder make up a small percentage of those with psychiatric conditions (approximately 6.4%), it is likely that those who display signs of disordered eating in the general population, such as overestimation of body weight and engaging in restrictive eating behaviours, is greater and increasing​[43–45]​.


Identification can be challenging as patients do not always readily present to services seeking support or even engage with the idea that there is something wrong​[46,47]​. There are several possible reasons for this; in the case of anorexia nervosa this may result from the egosyntonic (aligned with personal values and self-image) nature of the disorder, a distorted body image leading to the person seeing themselves as overweight or fat and a lack of insight into their difficulties​[48]​.

In binge eating disorder and bulimia nervosa, reluctance to seek support and talk to others about symptoms may be related to feelings of shame and disgust around purging (usually self-induced vomiting) and/or binging behaviours​[49,50]​. Often, presentation may be instigated by friends and family or be prompted by another factor unrelated to the disorder entirely. They may present with a general complaint of vague physical symptoms, such as difficulties with fatigue, dizziness or constipation, rather than explicitly stating they may have an eating disorder​[51–54]​.

Signs and symptoms

Signs and symptoms vary across the spectrum of eating disorders (see Table 1​[55,56]​). People with anorexia nervosa and bulimia nervosa will often engage in dieting behaviours, such as fasting, calorie counting, avoiding meals and using exercise, as a way of attempting to manage weight, as well as using diet pills, laxatives and diuretics​[57]​. Often people with an eating disorder will weigh themselves frequently and engage in other body checking behaviours such as assessing appearance, shape or size​[57]​.

Physical symptoms, such as sleep disturbance, delayed gastric emptying, feeling cold and poor energy levels, are often present as a consequence of inadequate nutrition and being underweight​[57]​. Those who self-induce vomiting may suffer from bloating, sore throats, fluid and electrolyte disturbances and dental problems​[58]​. Eating disorders can affect menstruation regardless of body mass index (BMI) and is not restricted to those with a diagnosis of anorexia nervosa​[59]​. Libido can also be negatively affected. Physical consequences of obesity, such as type 2 diabetes mellitus and hypertension, may be present in those who struggle with binge eating disorder​[60]​.

In people who significantly restrict their eating, semi-starvation can lead to depressed mood, anxiety, difficulties in concentration and obsessive-compulsive symptoms​[57]​. People with low BMI often display significant rigidity in their thinking and impaired decision-making abilities​[61]​. Anxiety and depression is also seen in people who binge eat and there is some suggestion that binging can function as a mood management strategy in the short term, while reinforcing low mood or anxiety as a longer term consequence​[62]​.


People with an eating disorder are likely to present in a variety of settings seeking support with a range of symptoms without necessarily disclosing difficulties with eating​[63–65]​. These symptoms are often gastrointestinal, gynecological or psychological (e.g. anxiety and depression) in nature so there is a need to consider an eating disorder as a differential diagnosis and screen for this when an eating disorder is suspected, rather than expect a person to disclose their difficulties.

For pharmacists, there may be multiple opportunities to support the identification of people with an eating disorder; for example, when over-the-counter medication is being used to facilitate weight loss or compensate for binging and there are frequent or multiple purchases of laxative or diuretics. There may also be opportunities to identify eating disorders during medication reviews, multidisciplinary team meetings or ward rounds when considering the health, wellbeing and behaviour of patients.

National Institute for Health and Care Excellence (NICE) guidance suggests the use of screening tools, such as the SCOFF test, to support the identification of eating disorders in primary care settings, although the use of these tools need not be limited to these settings​[12,66]​. SCOFF is a mnemonic produced from key words within the test (see Box 1​[66]​). Identification of eating disorders should not be made based on the results of screening tools alone.

Box 1: SCOFF test

S — Do you make yourself Sick because you feel uncomfortably full? 

C — Do you worry you have lost Control over how much you eat? 

O — Have you recently lost more than One stone (6.35kg) in a three-month period? 

F — Do you believe yourself to be Fat when others say you are too thin? 

F — Would you say Food dominates your life?

Following a positive screening or when an eating disorder is suspected owing to other reasons, a more detailed history can be taken asking for information such as further details regarding eating disorder behaviours, physical health complications and mental health difficulties; however, care should be taken with any attempt to gain further information about an individual’s presentation. It is important to balance the need for the assessment of symptoms and risk with the function of the conversation. For instance, the depth of assessment/information seeking will be different when the purpose is making a referral to specialist services compared with the aim of signposting to GP or other avenues of support (e.g. the eating disorders charity BEAT).

Any conversation regarding difficulties should be approached in a way that is sensitive and compassionate being mindful of the high levels of shame people with an eating disorder can experience. Adopting a communication style that is calm and empathetic and avoids making assumptions about the function of the eating disorder is likely to be the most helpful approach. Overly simplistic advice (e.g. ‘just eat more’ or ‘stop using laxatives’) should be avoided. 

If an eating disorder is suspected, gentle exploration of the person’s health (if visibly unwell) or behaviours (such as multiple purchases of laxative or diet aids) should be undertaken in privacy and after gaining consent. The key to any conversation is to raise the issue in a way that is non-judgmental and does not put the person under pressure. If the initial queries are met with denial, it is important to not react negatively. It may be that several conversations are necessary to develop a relationship that is trusting and safe enough to be able to discuss any concerns.  

If someone acknowledges their difficulties with food and eating in a community setting, signposting to their GP would be appropriate. It would be wise to follow up with the person if possible because people with an eating disorder often experience significant ambivalence with regards to recovery and may need further support to take the next steps in accessing appropriate treatment​[67]​. In other settings, such as inpatient wards or GP surgeries, it may be appropriate to contact a local eating disorder service for advice or to make a referral.

Service provision for the treatment of eating disorders may vary according to location, and advice should be sought from local services regarding the referral and treatment options that are available. There may be a variety of treatment options, including primary care services such as NHS Talking Therapies for Anxiety and Depression (formerly Improving Access to Psychological Therapies services), specialist eating disorder services in secondary care and offers from third sector providers. Access to these services may be based upon eating disorder type and/or severity, and services will likely require information regarding eating disorder symptoms/presentation, BMI, other co-morbid mental health difficulties and risk related to physical health and/or self-harm and suicide.  

Diagnosis and assessment

When assessment is conducted in specialist eating disorder services, a detailed history is taken to understand the symptoms, physical health and potential risk, as well as the social and psychological experiences of the person in order to make a diagnosis of an eating disorder(see Box 2). Physical health tests and examinations are often completed or ordered. Consideration is given to differential diagnoses and physical causes for the person’s symptoms are also ruled out.

Box 2: Patient assessment


  • Has there been a recent change in weight?
    • If so, how rapid, over what time period and how much by?
  • Is there dietary restriction and/or binging?
  • Is there a fear of gaining weight and/or body image disturbances?
  • Is there evidence of behaviours designed to compensate for intake (i.e. exercise, self-induced vomiting or misusing medications)?

Physical health

  • Is there evidence of physical health complications? Such as:
    • Fatigue;
    • Constipation, bloating or other gastrointestinal problems;
    • Reflux;
    • Hair loss;
    • Amenorrhoea;
    • Feeling cold;
    • Dental problems;
    • Lanugo.

Medication, recreational drugs and alcohol

  • Does the person misuse medication?
  • Is there use of recreational drugs?
  • Does the person misuse alcohol?

Mental health

  • Is there evidence of other mental health difficulties?

Social history and social support

  • Is there a history of trauma?
  • Have there been or are there any stressors at school, work or home?
  • Is there a family history of any mental health problems?
  • Does the person have a supportive network of family and/or friends?

Several physical examinations and investigations may be necessary for individuals with an eating disorder, especially in those with a low BMI and/or who engage in self-induced vomiting or other compensatory behaviours, such as abuse of laxative and diuretics (see Table 2​[68]​).  

Detailed information regarding assessment for people with an eating disorder can be found within NICE guidance NG69 and ‘Medical Emergencies in Eating Disorders: Guidance on Recognition and Management’​[12,69]​.  

There may be an expectation for basic physical health tests to have also been completed prior to referral, and the physical healthcare of people under eating disorder services can occur within primary care settings. This may be overseen and managed by the person’s GP, or in collaboration with specialist services, and is dependent on local commissioning.

Treatment and management

Treatment for an eating disorder is predominantly a combination of psychological therapy and nutritional advice/rehabilitation. Various modalities of therapy are available dependent on age and presentation (see Table 3 for NICE recommended modalities​[12]​). All modalities generally seek to regulate eating patterns and support the development of healthy coping strategies. In the case of anorexia nervosa, treatment also aims to support the restoration of weight, with the aim of reaching and maintaining a healthy BMI.  

Medications should not be offered as the sole treatment for an eating disorder, and there is limited evidence for efficacy in this population. The selective serotonin reuptake inhibitor fluoxetine can be used in bulimia nervosa and binge eating disorder where it can reduce binge-purge/binge cycles​[70–72]​. More recently, there is also some evidence that supports the use of topiramate (although this is often not well tolerated) in the treatment of bulimia nervosa and lisdexafetamine for binge eating disorder in order to reduce the frequency of binges, although neither medication is currently licensed for use in this way in the UK​[72]​

There is limited evidence to suggest that atypical antipsychotic medication can be helpful in people with severe anorexia nervosa with significant agitation, anxiety or delusional body image disturbances but they are not considered effective as a method of enhancing weight gain in this population and would be used off-licence​[73]​. Nonetheless, medication may be indicated to treat any co-morbid physical or mental health diagnosis and it is important to ensure that any underlying co-morbid difficulty, such as anxiety and depression, is treated adequately through either appropriate medication, therapy or a combination of the two.

Owing to the nature of eating disorders, there are often other management considerations, such as micro and macronutrient deficiencies. Therefore, psycho-education should be provided, and the person should be encouraged to manage this through diet. Recommendation of age-appropriate oral multivitamins could be considered until dietary intake is adequate​[12,72]​.

If there are significant macronutrient deficiencies that have led to low weight, the possibility of refeeding syndrome should be considered (see ‘Complications‘ for further information). The Royal College of Psychiatrists Medical Emergencies in Eating Disorders (MEED) guidance should be consulted and followed if necessary​[69]​. When there is a failure in low weight individuals to gain weight through increase of dietary intake, it may be appropriate to consider oral nutritional supplementation; however, this would not be first-line treatment and would be prescribed in line with oral nutritional supplementation guidance for as short a period as possible. Oral nutritional supplementation is usually only trialled following specialist dietetic assessment and on their advice​[74]​.

Differences between the management of eating disorders in adults and children and young people are usually in relation to psychological treatment modality. Certain physical risk thresholds will also be lower in children and young people owing to the potential effects of restriction of intake on growth and puberty​[75]​.

Considerations for medication risk management

When medications have been prescribed for people with an eating disorder, it is necessary for the impact of any potential malnutrition or eating disorder behaviours, such as self-induced vomiting, to be taken into account​[12]​. Eating disorder cognitions, such as the fear of weight gain, may lead to difficulties in compliance in medicines that have side effects related to this and counselling at the point of dispensing may be necessary to support compliance. When there are difficulties with compliance, alternative medications may have to be considered utilising support and guidance from pharmacists where needed.  

If medications may compromise physical heath (e.g. cardiac functioning), care should be taken to ensure that this is monitored in line with NICE guidance​[12]​. Pharmacists are able to highlight when this becomes necessary and support adherence to the monitoring process, as well as ensuring that potential adverse effects and/or interactions are considered and discussed with the patient as appropriate.

As previously discussed, medications such as stimulants, laxatives and/or diuretics may be misused by people with an eating disorder to support weight loss or prevent weight gain following binging and this should be considered during assessment of symptoms and behaviours​[76]​. Strategies for reduction and elimination of the use of such medications should be incorporated into treatment plans and there may be opportunities for pharmacists to support the development of these plans​[76]​. Pharmacists working in the community should be alert to requests for medications that may be inappropriate or excessive and be mindful of a potential opportunity for intervention and signposting to GP or local services when this is the case.

Management of comorbidities

People with an eating disorder may have various co-morbid diagnoses. These could include diabetes and other physical health problems, as well as mental health problems such as anxiety, depression or personality disorders. There are also known links between autistic spectrum condition (ASC) and difficulties with food and eating and high rates of co-morbid diagnosis especially in anorexia nervosa, although the exact neurobiological mechanisms are not known or understood​[77–79]​. When there is a comorbid diagnosis, care should be taken to ensure that these are considered and adequately treated if possible.  

If there is co-morbid ASC, person-centered adaptations and/or reasonable adjustments should be made to treatment to support recovery​[80]​. This may include providing a sensory friendly environment, communication-based changes (e.g. speak clearly, slowly and succinctly, using direct language) or adjustments to minimise uncertainty, such as confirmed appointment times and seeing people at the time agreed where possible. It may be that the person has an autism passport (where individuals can express how their autism effects them and detail ways that suitable adjustments can be made). If so, this should be referred to in order to support the person to engage in healthcare-related appointments and activities, as well as reduce barriers to effective treatment​[81]​.

In the case of a co-morbid diabetes diagnosis, there is risk of misuse of insulin in order to facilitate weight loss. Treatment for people with an eating disorder and diabetes should be a collaboration between eating disorder and diabetes teams, and both NICE guidance and MEED guidance, where appropriate, should be followed in order to support safe and effective treatment​[12,69]​.


There are several possible physical complications that may occur as a consequence of developing an eating disorder. In restrictive presentations and with a low BMI, there is the risk of developing low bone mineral density leading to osteopenia and osteoporosis. Guidance suggests that bone mineral density scans should be considered after one year of being underweight in children and young people and after two years of being underweight in adults​[12]​. This should be considered earlier if there is bone pain or recurrent fractures. The mainstays of therapy in this population should be restoration of weight and increase in calcium and vitamin D, ideally through diet alone, although supplementation may be appropriate where this is not possible​[82,83]​

Should it be necessary (for example where osteopenia has developed into osteoporosis), other treatment options are available, such as hormonal treatments (oestrogen) or bisphosphonate. However, specialist advice and support should be sought​[12]​.

If there has been significant restriction of food intake for a number of days and food (especially carbohydrates) is reintroduced, there is a risk of re-feeding syndrome. This is a potentially fatal condition that can occur when nutrition is given to people following starvation. The sudden reintroduction of food leads to metabolic disturbances that result in neurological and cardiovascular problems​[84]​. People at high risk of re-feeding syndrome (i.e. those who have a significantly low BMI), have had little to no intake for more than four days and blood abnormalities such as low electrolytes and white blood count, require high levels of monitoring and consideration should be given to managing this in a hospital setting. If risk of re-feeding is lower, this can be managed safely in community settings; however, careful medical monitoring is required​[69]​. In all cases where re-feeding syndrome could be a possibility or people with an eating disorder are admitted to medical or psychiatric wards, MEED guidance should be consulted and followed as appropriate.

Other complications as a consequence of an eating disorder include fluid and electrolyte disturbance due to over-hydration or dehydration, either from restriction of fluids or as a consequence of purging. Care should be taken during assessment to understand the eating disorder behaviours and where there is risk of fluid and electrolyte disturbances, medical monitoring should occur. If there is cause for concern, consideration should be given to the appropriate intervention (e.g. potassium supplementation in the case of hypokalaemia). Acute medical care should be given in the case of any severe physical health complication​[12]​.

When complications are less severe (for example dental problems owing to self-induced vomiting), advice on the management and prevention of this can be offered in line with NICE guidance​[12]​.


  • Display empathy and communicate in a calm, non-judgmental manner;
  • Try to raise any issue around food and eating in a sensitive and compassionate way;
  • Signpost to the GP or other sources of support and information. If appropriate, consult specialist services for advice and/or referral;
  • Take time to understand the views and concerns of the person with regard to their medication use and be prepared to answer questions around side effects, especially potential weight gain;
  • Encourage them to return if they experience any adverse effects from medication;
  • People with an eating disorder may present with a range of vague symptoms or complaints related to their eating disorder rather than complaints about the eating disorder itself;
  • Care and compassion should be used to assess for symptoms of an eating disorder being mindful of the acute shame people may feel about their difficulties;
  • Early intervention is often key to the successful treatment of an eating disorder and signposting at any level can be helpful;
  • Collaboration should occur between services to support people with an eating disorder to ensure safe and effective treatment;
  • The role of the pharmacist is not limited to guidance and support with medication, side effects and psychoeducation to support compliance, but may also include early identification of eating disorder, signposting and referral, as well as supporting to manage physical health risk and complications in relation to eating disorder;
  • Some medications can be misused by people with an eating disorder in order to manage weight gain or aid weight loss;
  • Eating disorders can have physical and psychological impacts that may have implications for the safe use of medicines.

Helpful resources

  1. 1
    Arcelus J, Mitchell AJ, Wales J, et al. Mortality Rates in Patients With Anorexia Nervosa and Other Eating Disorders. Arch Gen Psychiatry. 2011;68:724. doi:10.1001/archgenpsychiatry.2011.74
  2. 2
    van Hoeken D, Hoek HW. Review of the burden of eating disorders: mortality, disability, costs, quality of life, and family burden. Current Opinion in Psychiatry. 2020;33:521–7. doi:10.1097/yco.0000000000000641
  3. 3
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington DC: : American Psychiatric Publishing 2013. (accessed Oct 2023).
  4. 4
    ICD-11 for Mortality and Morbidity Statistics . World Health Organization. 2023. (accessed Oct 2023).
  5. 5
    Fairburn CG, Cooper Z, Shafran R. Cognitive behaviour therapy for eating disorders: a “transdiagnostic” theory and treatment. Behaviour Research and Therapy. 2003;41:509–28. doi:10.1016/s0005-7967(02)00088-8
  6. 6
    Kaplan AS, Garfinkel PE. Difficulties in Treating Patients with Eating Disorders: A Review of Patient and Clinician Variables. Can J Psychiatry. 1999;44:665–70. doi:10.1177/070674379904400703
  7. 7
    Halmi KA. Perplexities of treatment resistence in eating disorders. BMC Psychiatry. 2013;13. doi:10.1186/1471-244x-13-292
  8. 8
  9. 9
    Micali N, Hagberg KW, Petersen I, et al. The incidence of eating disorders in the UK in 2000–2009: findings from the General Practice Research Database. BMJ Open. 2013;3:e002646. doi:10.1136/bmjopen-2013-002646
  10. 10
    Hospital admissions for eating disorders increased by 84% in the last five years. Royal College of Psychiatrists. 2022. (accessed Oct 2023).
  11. 11
    Adult Psychiatric Morbidity Survey: Survey of Mental Health and Wellbeing, England, 2014. NHS Digital. 2016. (accessed Oct 2023).
  12. 12
    Eating disorders: recognition and treatment. National Institute for Health and Care Excellence. 2017. (accessed Oct 2023).
  13. 13
    Polivy J, Herman CP. Causes of Eating Disorders. Annu. Rev. Psychol. 2002;53:187–213. doi:10.1146/annurev.psych.53.100901.135103
  14. 14
    Keys A, Brozek J, Henschel A, et al. The Biology of Human Starvation. Minnesota, United States: : University of Minnesota Press 1950. (accessed Oct 2023).
  15. 15
    Södersten P, Bergh C, Zandian M. Understanding eating disorders. Hormones and Behavior. 2006;50:572–8. doi:10.1016/j.yhbeh.2006.06.030
  16. 16
    Müller MJ, Bosy-Westphal A, Heymsfield SB. Is there evidence for a set point that regulates human body weight? F1000 Med Rep. 2010;2. doi:10.3410/m2-59
  17. 17
    Bulik CM, Blake L, Austin J. Genetics of Eating Disorders. Psychiatric Clinics of North America. 2019;42:59–73. doi:10.1016/j.psc.2018.10.007
  18. 18
    Bulik CM, Sullivan PF, Fear JI, et al. Eating disorders and antecedent anxiety disorders: a controlled study. Acta Psychiatr Scand. 1997;96:101–7. doi:10.1111/j.1600-0447.1997.tb09913.x
  19. 19
    Hübel C, Marzi SJ, Breen G, et al. Epigenetics in eating disorders: a systematic review. Mol Psychiatry. 2018;24:901–15. doi:10.1038/s41380-018-0254-7
  20. 20
    Becker AE, Keel P, Andersonfye EP, et al. Genes and/or Jeans? Journal of Addictive Diseases. 2004;23:81–103. doi:10.1300/j069v23n03_07
  21. 21
    Culbert KM, Racine SE, Klump KL. Research Review: What we have learned about the causes of eating disorders – a synthesis of sociocultural, psychological, and biological research. Child Psychology Psychiatry. 2015;56:1141–64. doi:10.1111/jcpp.12441
  22. 22
    Anderluh MB, Tchanturia K, Rabe-Hesketh S, et al. Childhood Obsessive-Compulsive Personality Traits in Adult Women With Eating Disorders: Defining a Broader Eating Disorder Phenotype. AJP. 2003;160:242–7. doi:10.1176/appi.ajp.160.2.242
  23. 23
    Borda Mas M, Avargues Navarro ML, Lopez Jimenez AM, et al. Personality traits and eating disorders: Mediating effects of self-esteem and perfectionism. International Journal of Clinical and Health Psychology 2011;11:205–27.
  24. 24
    Wade TD, O’Shea A, Shafran R. Perfectionism and Eating Disorders. Perfectionism, Health, and Well-Being. 2015;:205–22. doi:10.1007/978-3-319-18582-8_9
  25. 25
    Colmsee I-SO, Hank P, Bošnjak M. Low Self-Esteem as a Risk Factor for Eating Disorders. Zeitschrift für Psychologie. 2021;229:48–69. doi:10.1027/2151-2604/a000433
  26. 26
    Troisi A, Di Lorenzo G, Alcini S, et al. Body Dissatisfaction in Women With Eating Disorders: Relationship to Early Separation Anxiety and Insecure Attachment. Psychosomatic Medicine. 2006;68:449–53. doi:10.1097/01.psy.0000204923.09390.5b
  27. 27
    Tasca GA, Balfour L. Attachment and eating disorders: A review of current research. Intl J Eating Disorders. 2014;47:710–7. doi:10.1002/eat.22302
  28. 28
    Holzer SR, Uppala S, Wonderlich SA, et al. Mediational significance of PTSD in the relationship of sexual trauma and eating disorders. Child Abuse & Neglect. 2008;32:561–6. doi:10.1016/j.chiabu.2007.07.011
  29. 29
    Brewerton TD. Stress, Trauma, and Adversity as Risk Factors in the Development of Eating Disorders. The Wiley Handbook of Eating Disorders. 2015;:445–60. doi:10.1002/9781118574089.ch34
  30. 30
    MacNeil L, Esposito-Smythers C, Mehlenbeck R, et al. The effects of avoidance coping and coping self-efficacy on eating disorder attitudes and behaviors: A stress-diathesis model. Eating Behaviors. 2012;13:293–6. doi:10.1016/j.eatbeh.2012.06.005
  31. 31
    Soukup V, Beiler M, Terrell F. Stress, coping style, and problem solving ability among eating-disordered inpatients. J Clin Psychol 1990;46:592–9. doi:10.1002/1097-4679(199009)46:5<592::aid-jclp2270460508>;2-y
  32. 32
    Sassaroli S, Ruggiero GM. The role of stress in the association between low self-esteem, perfectionism, and worry, and eating disorders. Int. J. Eat. Disord. 2005;37:135–41. doi:10.1002/eat.20079
  33. 33
    Pike KM, Hoek HW, Dunne PE. Cultural trends and eating disorders. Current Opinion in Psychiatry. 2014;27:436–42. doi:10.1097/yco.0000000000000100
  34. 34
    Nasser M. Eating disorders: The cultural dimension. Soc Psychiatry Psychiatr Epidemiol. 1988;23:184–7. doi:10.1007/bf01794786
  35. 35
    Yang M. Seattle public schools sue social media platforms for youth ‘mental health crisis’. The Guardian. 2023. (accessed Oct 2023).
  36. 36
    Social Media Use Is Linked to Brain Changes in Teens, Research Finds. New York Times. 2023. (accessed Oct 2023).
  37. 37
    Sadagheyani HE, Tatari F. Investigating the role of social media on mental health. MHSI. 2020;25:41–51. doi:10.1108/mhsi-06-2020-0039
  38. 38
    Marks RJ, De Foe A, Collett J. The pursuit of wellness: Social media, body image and eating disorders. Children and Youth Services Review. 2020;119:105659. doi:10.1016/j.childyouth.2020.105659
  39. 39
    Stice E, Desjardins CD. Interactions between risk factors in the prediction of onset of eating disorders: Exploratory hypothesis generating analyses. Behaviour Research and Therapy. 2018;105:52–62. doi:10.1016/j.brat.2018.03.005
  40. 40
    Stice E, Marti CN, Durant S. Risk factors for onset of eating disorders: Evidence of multiple risk pathways from an 8-year prospective study. Behaviour Research and Therapy. 2011;49:622–7. doi:10.1016/j.brat.2011.06.009
  41. 41
    Position statement on early intervention for eating disorders. Royal College of Psychiatrists. 2019. (accessed Oct 2023).
  42. 42
    Fernández‐Aranda F, Treasure J, Paslakis G, et al. The impact of duration of illness on treatment nonresponse and drop‐out: Exploring the relevance of enduring eating disorder concept. Euro Eating Disorders Rev. 2021;29:499–513. doi:10.1002/erv.2822
  43. 43
    Adult Psychiatric Morbidity in England – 2007, Results of a household survey. NHS Digital. 2009. (accessed Oct 2023).
  44. 44
    Schmidt U. Epidemiology and aetiology of eating disorders. Psychiatry. 2005;4:5–9. doi:10.1383/psyt.
  45. 45
    Solmi F, Sharpe, PhD H, Gage SH, et al. Changes in the Prevalence and Correlates of Weight-Control Behaviors and Weight Perception in Adolescents in the UK, 1986-2015. JAMA Pediatr. 2021;175:267. doi:10.1001/jamapediatrics.2020.4746
  46. 46
    Grillot CL, Keel PK. Barriers to seeking treatment for eating disorders: The role of self‐recognition in understanding gender disparities in who seeks help. Intl J Eating Disorders. 2018;51:1285–9. doi:10.1002/eat.22965
  47. 47
    Ali K, Farrer L, Fassnacht DB, et al. Perceived barriers and facilitators towards help‐seeking for eating disorders: A systematic review. Intl J Eating Disorders. 2016;50:9–21. doi:10.1002/eat.22598
  48. 48
    Abbate-Daga G, Amianto F, Delsedime N, et al. Resistance to treatment and change in anorexia nervosa: a clinical overview. BMC Psychiatry. 2013;13. doi:10.1186/1471-244x-13-294
  49. 49
    Kornstein SG, Kunovac JL, Herman BK, et al. Recognizing Binge-Eating Disorder in the Clinical Setting. Prim. Care Companion CNS Disord. 2016. doi:10.4088/pcc.15r01905
  50. 50
    Ali K, Fassnacht DB, Farrer L, et al. What prevents young adults from seeking help? Barriers toward help‐seeking for eating disorder symptomatology. Intl J Eating Disorders. 2020;53:894–906. doi:10.1002/eat.23266
  51. 51
    Williams P, Goodie J, Motsinger C. Treating eating disorders in primary care. Am Fam Physician 2008;77:187–95.
  52. 52
    Surgenor LJ, Maguire S. Assessment of anorexia nervosa: an overview of universal issues and contextual challenges. J Eat Disord. 2013;1. doi:10.1186/2050-2974-1-29
  53. 53
    Kästner D, Weigel A, Buchholz I, et al. Facilitators and barriers in anorexia nervosa treatment initiation: a qualitative study on the perspectives of patients, carers and professionals. J Eat Disord. 2021;9. doi:10.1186/s40337-021-00381-0
  54. 54
    Johnston O, Fornai G, Cabrini S, et al. Feasibility and acceptability of screening for eating disorders in primary care. Family Practice. 2007;24:511–7. doi:10.1093/fampra/cmm029
  55. 55
    Jones WR, Schelhase M, Morgan JF. Eating disorders: clinical features and the role of the general psychiatrist. Adv. psychiatr. treat. 2012;18:34–43. doi:10.1192/apt.bp.109.007245
  56. 56
    Wang SB, Jones PJ, Dreier M, et al. Core psychopathology of treatment-seeking patients with binge-eating disorder: a network analysis investigation. Psychol. Med. 2018;49:1923–8. doi:10.1017/s0033291718002702
  57. 57
    Murphy R, Straebler S, Cooper Z, et al. Cognitive Behavioral Therapy for Eating Disorders. Psychiatric Clinics of North America. 2010;33:611–27. doi:10.1016/j.psc.2010.04.004
  58. 58
    Symptoms – Bulimia. NHS England. 2023. (accessed Oct 2023).
  59. 59
    Poyastro Pinheiro A, Thornton LM, Plotonicov KH, et al. Patterns of menstrual disturbance in eating disorders. Int. J. Eat. Disord. 2007;40:424–34. doi:10.1002/eat.20388
  60. 60
    Sheehan DV, Herman BK. The Psychological and Medical Factors Associated With Untreated Binge Eating Disorder. Prim. Care Companion CNS Disord. 2015. doi:10.4088/pcc.14r01732
  61. 61
    Abbate-Daga G, Buzzichelli S, Amianto F, et al. Cognitive flexibility in verbal and nonverbal domains and decision making in anorexia nervosa patients: a pilot study. BMC Psychiatry. 2011;11. doi:10.1186/1471-244x-11-162
  62. 62
    Rosenbaum DL, White KS. The role of anxiety in binge eating behavior: a critical examination of theory and empirical literature. Health Psych Res. 2013;1:19. doi:10.4081/hpr.2013.714
  63. 63
    Staller K, Abber SR, Burton Murray H. The intersection between eating disorders and gastrointestinal disorders: a narrative review and practical guide. The Lancet Gastroenterology &amp; Hepatology. 2023;8:565–78. doi:10.1016/s2468-1253(22)00351-x
  64. 64
    Riedlinger C, Schmidt G, Weiland A, et al. Which Symptoms, Complaints and Complications of the Gastrointestinal Tract Occur in Patients With Eating Disorders? A Systematic Review and Quantitative Analysis. Front. Psychiatry. 2020;11. doi:10.3389/fpsyt.2020.00195
  65. 65
    Ogg EC, Millar HR, Pusztai EE, et al. General practice consultation patterns preceding diagnosis of eating disorders. Int. J. Eat. Disord. 1997;22:89–93. doi:10.1002/(sici)1098-108x(199707)22:1<89::aid-eat12>;2-d
  66. 66
    Morgan JF, Reid F, Lacey JH. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. BMJ. 1999;319:1467–8. doi:10.1136/bmj.319.7223.1467
  67. 67
    Geller J, Zaitsoff SL, Srikameswaran S. Tracking Readiness and Motivation for Change in Individuals with Eating Disorders Over the Course of Treatment. Cogn Ther Res. 2005;29:611–25. doi:10.1007/s10608-005-5774-1
  68. 68
    How should I assess a person with a suspected eating disorder? National Institute for Health and Care Excellence. 2019. (accessed Oct 2023).
  69. 69
    Medical Emergencies in Eating Disorders: Guidance on Recognition and Management College Report CR233. Royal College of Psychiatrists. 2023. (accessed Oct 2023).
  70. 70
    Davis LE, Attia E. Recent advances in therapies for eating disorders. F1000Res. 2019;8:1693. doi:10.12688/f1000research.19847.1
  71. 71
    Muratore AF, Attia E. Psychopharmacologic Management of Eating Disorders. Curr Psychiatry Rep. 2022;24:345–51. doi:10.1007/s11920-022-01340-5
  72. 72
    Drug Treatment of Other Psychiatric Conditions. The Maudsley Prescribing Guidelines in Psychiatry. 2021;:757–75. doi:10.1002/9781119870203.mpg009
  73. 73
    Mehler-Wex C, Romanos M, Kirchheiner J, et al. Atypical antipsychotics in severe anorexia nervosa in children and adolescents—review and case reports. Eur. Eat. Disorders Rev. 2008;16:100–8. doi:10.1002/erv.843
  74. 74
    ‘MUST’ Calculator. Malnourish Action Group. (accessed Oct 2023).
  75. 75
    Neale J, Pais SMA, Nicholls D, et al. What Are the Effects of Restrictive Eating Disorders on Growth and Puberty and Are Effects Permanent? A Systematic Review and Meta-Analysis. Journal of Adolescent Health. 2020;66:144–56. doi:10.1016/j.jadohealth.2019.08.032
  76. 76
    Gregorowski C, Seedat S, Jordaan GP. A clinical approach to the assessment and management of co-morbid eating disorders and substance use disorders. BMC Psychiatry. 2013;13. doi:10.1186/1471-244x-13-289
  77. 77
    Blinder BJ, Cumella EJ, Sanathara VA. Psychiatric Comorbidities of Female Inpatients With Eating Disorders. Psychosomatic Medicine. 2006;68:454–62. doi:10.1097/01.psy.0000221254.77675.f5
  78. 78
    Hudson JI, Hiripi E, Pope HG Jr, et al. The Prevalence and Correlates of Eating Disorders in the National Comorbidity Survey Replication. Biological Psychiatry. 2007;61:348–58. doi:10.1016/j.biopsych.2006.03.040
  79. 79
    Huke V, Turk J, Saeidi S, et al. Autism Spectrum Disorders in Eating Disorder Populations: A Systematic Review. Eur. Eat. Disorders Rev. 2013;21:345–51. doi:10.1002/erv.2244
  80. 80
    Kelly C, Kelly C. What is Different about Eating Disorders for Those with Autistic Spectrum Condition? International Journal of Psychiatry Research 2021;4:1–8.
  81. 81
    Haydon C, Doherty M, Davidson IA. Autism: making reasonable adjustments in healthcare. Br J Hosp Med. 2021;82:1–11. doi:10.12968/hmed.2021.0314
  82. 82
    Misra M, Klibanski A. Bone health in anorexia nervosa. Current Opinion in Endocrinology, Diabetes &amp; Obesity. 2011;18:376–82. doi:10.1097/med.0b013e32834b4bdc
  83. 83
    Drabkin A, Rothman MS, Wassenaar E, et al. Assessment and clinical management of bone disease in adults with eating disorders: a review. J Eat Disord. 2017;5. doi:10.1186/s40337-017-0172-0
  84. 84
    Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ. 2008;336:1495–8. doi:10.1136/bmj.a301
Last updated
CPD module

Test your knowledge by completing the questions associated with this article.

More CPD modules are available in the 'My CPD' section of your account.

Start module
Peer reviewed article
This article has been peer reviewed by relevant subject experts prior to acceptance for publication. The reviewers declared no relevant affiliations or financial involvement with any organisation or entity with a financial involvement with any organisation or entity with a financial interest in or in financial conflict with the subject matter or materials discussed in this article.
The Pharmaceutical Journal, PJ, October 2023, Vol 311, No 7978;311(7978)::DOI:10.1211/PJ.2023.1.198074

    Please leave a comment 

    You might also be interested in…